Omkar Pharmachem Ltd
₹ 10.2
4.73%
05 Oct
1:44 p.m.
- Market Cap ₹ 10.3 Cr.
- Current Price ₹ 10.2
- High / Low ₹ 29.7 / 7.08
- Stock P/E 114
- Book Value ₹ 36.3
- Dividend Yield 0.00 %
- ROCE 0.74 %
- ROE 0.52 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.27 times its book value
- Debtor days have improved from 41.6 to 23.3 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 11.7% over past five years.
- Promoter holding is low: 0.03%
- Company has a low return on equity of 1.23% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.27 | 0.54 | 0.54 | 0.54 | 0.54 | 0.47 | 0.43 | |
| 0.06 | 0.12 | 0.22 | 0.24 | 0.38 | 0.26 | 0.24 | 0.27 | 0.22 | 0.25 | 0.24 | 0.31 | 0.31 | |
| Operating Profit | -0.06 | -0.12 | -0.22 | -0.24 | -0.38 | -0.21 | 0.03 | 0.27 | 0.32 | 0.29 | 0.30 | 0.16 | 0.12 |
| OPM % | -420.00% | 11.11% | 50.00% | 59.26% | 53.70% | 55.56% | 34.04% | 27.91% | |||||
| 0.00 | 0.00 | 0.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.01 | 0.04 | 0.05 | 0.06 | 0.06 | 0.05 | 0.03 | 0.02 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Profit before tax | -0.06 | -0.12 | 0.27 | -0.25 | -0.42 | -0.26 | -0.03 | 0.21 | 0.27 | 0.26 | 0.27 | 0.17 | 0.12 |
| Tax % | 0.00% | 0.00% | 18.52% | 0.00% | 0.00% | 0.00% | -866.67% | 14.29% | 25.93% | 23.08% | 25.93% | 23.53% | |
| -0.06 | -0.12 | 0.22 | -0.26 | -0.42 | -0.26 | 0.22 | 0.18 | 0.20 | 0.19 | 0.20 | 0.12 | 0.09 | |
| EPS in Rs | -0.06 | -0.12 | 0.22 | -0.26 | -0.42 | -0.26 | 0.22 | 0.18 | 0.20 | 0.19 | 0.20 | 0.12 | 0.09 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | -5% |
| TTM: | -23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | -11% |
| 3 Years: | -16% |
| TTM: | -50% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -13% |
| 3 Years: | -22% |
| 1 Year: | -64% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 2% |
| 3 Years: | 1% |
| Last Year: | 1% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 |
| Reserves | -0.81 | -0.93 | -0.71 | -0.96 | -1.38 | -1.64 | -1.42 | -1.24 | -1.04 | -0.85 | -0.65 | 26.56 |
| 0.01 | 0.00 | 0.00 | 0.24 | 0.58 | 0.87 | 0.90 | 0.93 | 0.62 | 0.30 | 0.12 | 0.00 | |
| 0.13 | 0.57 | 0.06 | 0.04 | 0.05 | 0.06 | 0.08 | 0.06 | 0.07 | 0.07 | 0.05 | 0.05 | |
| Total Liabilities | 9.41 | 9.72 | 9.43 | 9.40 | 9.33 | 9.37 | 9.64 | 9.83 | 9.73 | 9.60 | 9.60 | 36.69 |
| 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 36.38 |
| 0.10 | 0.41 | 0.13 | 0.09 | 0.03 | 0.07 | 0.34 | 0.52 | 0.43 | 0.29 | 0.29 | 0.31 | |
| Total Assets | 9.41 | 9.72 | 9.43 | 9.40 | 9.33 | 9.37 | 9.64 | 9.83 | 9.73 | 9.60 | 9.60 | 36.69 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.05 | 0.34 | -0.77 | -0.25 | -0.30 | -0.21 | 0.02 | 0.20 | 0.28 | 0.30 | 0.24 | 0.23 | |
| 0.00 | 0.00 | 0.49 | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 | 0.00 | |
| 0.00 | -0.01 | 0.01 | 0.23 | 0.30 | 0.24 | -0.02 | -0.03 | -0.35 | -0.35 | -0.20 | -0.12 | |
| Net Cash Flow | -0.05 | 0.33 | -0.28 | -0.03 | 0.00 | 0.02 | 0.00 | 0.17 | -0.08 | -0.06 | 0.04 | 0.11 |
| Free Cash Flow | -0.05 | 0.34 | -0.29 | -0.26 | -0.30 | -0.21 | 0.02 | 0.19 | 0.28 | 0.29 | 0.24 | 0.23 |
| CFO/OP | 83% | -283% | 327% | 104% | 79% | 100% | 67% | 74% | 88% | 103% | 80% | 150% |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 146.00 | 40.56 | 54.07 | 87.87 | 33.80 | 67.59 | 23.30 | |||||
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 146.00 | 40.56 | 54.07 | 87.87 | 33.80 | 67.59 | 23.30 | |||||
| Working Capital Days | -6,570.00 | -1,270.74 | -608.33 | -378.52 | -162.22 | -6.76 | 23.30 | |||||
| ROCE % | -0.64% | -1.30% | -2.27% | -2.56% | -4.08% | -2.26% | 0.32% | 2.79% | 3.29% | 3.02% | 3.04% | 0.74% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Number of permanent employees employees |
|
|||||||||
| Equity shares held in A.B. Sugars Ltd shares |
||||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Closure of Trading Window
- Trading window closes from October 1, 2026 until 48 hours after Q2 FY26 results.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Dear Sir, Please find Newspaper Publication regarding special window for transfer and dematerialization (demat) of physical shares.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Dear Sir, Please find Newspaper Publication under Reg 47 of SEBI (LODR) Regulations, 2015 regarding the 31st Annual General Meeting of the Company.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1][2]
OPL is in the business of pharmaceuticals,
chemicals, including Specialty chemicals,
Ciba Specialty Chemicals, Organic chemicals, etc., and to provide management and business support services. Currently, the company is only
engaged in the business of providing support services related to activities.